<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR530.html">Part 530
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 530.20  Conditions for permitted extralabel animal and human
                            </h3>
                            <p class="depth1"><em>(a)</em> The following conditions must be met for a permitted extralabel use in food-producing animals of approved new animal and human drugs:</p><p class="depth2"><em>(1)</em> There is no approved new animal drug that is labeled for such use and that contains the same active ingredient which is in the required dosage form and concentration, except where a veterinarian finds, within the context of a valid veterinarian-client-patient relationship, that the approved new animal drug is clinically ineffective for its intended use.</p><p class="depth2"><em>(2)</em> Prior to prescribing or dispensing an approved new animal or human drug for an extralabel use in food animals, the veterinarian must:</p><p class="depth3"><em>(i)</em> Make a careful diagnosis and evaluation of the conditions for which the drug is to be used;</p><p class="depth3"><em>(ii)</em> Establish a substantially extended withdrawal period prior to marketing of milk, meat, eggs, or other edible products supported by appropriate scientific information, if applicable;</p><p class="depth3"><em>(iii)</em> Institute procedures to assure that the identity of the treated animal or animals is carefully maintained; and</p><p class="depth3"><em>(iv)</em> Take appropriate measures to assure that assigned timeframes for withdrawal are met and no illegal drug residues occur in any food-producing animal subjected to extralabel treatment.</p><p class="depth1"><em>(b)</em> The following additional conditions must be met for a permitted extralabel use of in food-producing animals an approved human drug, or of an animal drug approved only for use in animals not intended for human consumption:</p><p class="depth2"><em>(1)</em> Such use must be accomplished in accordance with an appropriate medical rationale; and</p><p class="depth2"><em>(2)</em> If scientific information on the human food safety aspect of the use of the drug in food-producing animals is not available, the veterinarian must take appropriate measures to assure that the animal and its food products will not enter the human food supply.</p><p class="depth1"><em>(c)</em> Extralabel use of an approved human drug in a food-producing animal is not permitted under this part if an animal drug approved for use in food-producing animals can be used in an extralabel manner for the particular use.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
